Multi-System Inflammatory Syndrome in Neonates (MIS-N) - Clinical Profile and Outcomes - A Prospective Cohort Study
DOI:
https://doi.org/10.6000/1929-4247.2023.12.03.2Keywords:
MIS-N, COVID-19, Neonate, immunomodulatorsAbstract
Aims: To analyze the clinical spectrum in Neonates with MIS-N based on the time of presentation and also to assess the use of immunomodulator therapy in MIS-N.
Subjects and Methods: We studied 100 neonates delivered at BLDE (DU) Shri B M Patil Medical College Hospital admitted to Level III-A NICU from JULY 2020 to MAY 2021. 98 neonates had high titers of IG G antibodies and were negative for COVID Antigen. We categorized the cohorts into EARLY MIS-N (<72 hrs) and LATE MIS-N (>72 hrs).
Results: 58 presented as EARLY MIS-N with Respiratory distress (RD) in 40 (70%), cardiac dysfunction 34 (60%), PPHN 12(20%), Fever 12(20%), seizures 12(20%), encephalopathy in 6(10%), sepsis-like features 6(10%), had elevated inflammatory markers like CRP (30%), D-Dimer (70%), Ferritin (30%), cardiac biomarkers like BNP (60%), LDH (30%) and ECHO showing LV dysfunction in 50%. LATE MIS-N presented mostly with fever 28(70%), sepsis-like features 24(60%), Respiratory Distress in 16(40%), cardiac dysfunction 12 (30%), hypoglycemia 4(10%), parotitis 4(10%), had significantly elevated inflammatory markers like CRP (70%), D-Dimer (50%), Ferritin (70%), cardiac biomarkers like BNP (40%), LDH (20%) and ECHO showing LV dysfunction in 20%, dilated coronaries in 20 %, PPHN in 10%. Oxygen and respiratory support requirements were higher in EARLY presenters and IVIG and steroid requirements were more in LATE presenters.
Conclusion: We observed that maternal SARS-COV-2 antibodies transferred transplacentally and neonatal antibodies acquired after COVID-19 infection can cause MIS-N in neonates. Immunomodulator therapy is required in severe cases of MIS-N only.
References
Al Ameer HH, Al Kadhem SM, Busaleh F, Al Khwaitm S, Llaguno MBB. Multi-system inflammatory syndrome in children temporally related to COVID-19: a case report from Saudi Arabia. Cureus 2020; 12(9): e10589. https://doi.org/10.7759/cureus.10589 DOI: https://doi.org/10.7759/cureus.10589
Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, Gupta A. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr Respir Rev 2021; 38: 51-57. https://doi.org/10.1016/j.prrv.2020.08.001 DOI: https://doi.org/10.1016/j.prrv.2020.08.001
Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children (Basel) 2020; 7(7): 69. https://doi.org/10.3390/children7070069 DOI: https://doi.org/10.3390/children7070069
Flannery DD, Gouma S, Dhudasia MB, Mukhopadhyay S, Pfeifer MR, Woodford EC, Triebwasser JE, Gerber JS, Morris JS, Weirick ME, et al. Assessment of Maternal and Neonatal CoRD Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. JAMA Pediatr 2021. https://doi.org/10.1001/jamapediatrics.2021.0038 DOI: https://doi.org/10.1001/jamapediatrics.2021.0038
Pawar R, Gavade V, Patil N, Mali V, Girwalkar A, Tarkasband V, et al. Neonatal Multi-system Inflammatory Syndrome (MIS-N) associated with prenatal maternal SARS-CoV-2: a case series. Children 2021; 8(7): 572. https://doi.org/10.3390/children8070572 DOI: https://doi.org/10.3390/children8070572
Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patient's withCOVID-19. Nat Med 2020; 26(6): 845-848. https://doi.org/10.1038/s41591-020-0897-1 DOI: https://doi.org/10.1038/s41591-020-0897-1
Orlanski-Meyer E, Yogev D, Auerbach A, et al. Multi-system Inflammatory Syndrome in Children associated with severe acute respiratory syndrome coronavirus-2 in an 8-week-old infant. J Pediatric Infect Dis Soc 2020; 9(6): 781-784. https://doi.org/10.1093/jpids/piaa137 DOI: https://doi.org/10.1093/jpids/piaa137
Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP, et al. Factors linked to severe outcomes in multi-system inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health 2021; 5(5): 323-331. https://doi.org/10.1016/S2352-4642(21)00050-X DOI: https://doi.org/10.1016/S2352-4642(21)00050-X
Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multi-system Inflammatory Syndrome in Children in New York State. N Engl J Med 2020; 383(4): 347-358. https://doi.org/10.1056/NEJMoa2021756 DOI: https://doi.org/10.1056/NEJMoa2021756
Lima ARO, CaRDoso CC, Bentim PRB, Voloch CM, Rossi ÁD, da Costa RMMSC, et al. Maternal SARS-CoV-2 infection associated to systemic inflammatory response and pericaRDial effusion in the neonate: a case report. J Pediatric Infect Dis Soc 2021; 10(4): 536-539. https://doi.org/10.1093/jpids/piaa133 DOI: https://doi.org/10.1093/jpids/piaa133
Kappanayil M, Balan S, Alawani S, et al. Multi-system inflammatory syndrome in a neonate, temporally associated with prenatal exposure to SARS-CoV-2: a case report. Lancet Child Adolesc Health 2021; 5(4): 304-308. https://doi.org/10.1016/S2352-4642(21)00055-9 DOI: https://doi.org/10.1016/S2352-4642(21)00055-9
Khaund Borkotoky R, Banerjee Barua P, Paul SP, Heaton PA. COVID-19-Related Potential Multi-system Inflammatory Syndrome in Childhood in a Neonate Presenting as Persistent Pulmonary Hypertension of the Neonate. Pediatr Infect Dis J 2021; 40(4): e162-e164. https://doi.org/10.1097/INF.0000000000003054 DOI: https://doi.org/10.1097/INF.0000000000003054
Divekar AA, Patamasucon P, Benjamin JS. Presumptive neonatal multi-system inflammatory syndrome in children associated with coronavirus disease 2019. Am J Perinatol 2021; 38: 632-636. https://doi.org/10.1055/s-0041-1726318 DOI: https://doi.org/10.1055/s-0041-1726318
Shaiba LA, Hadid A, Altirkawi KA, et al. Case report: Neonatal multi-system inflammatory syndrome associated with SARS-CoV-2 exposure in two cases from Saudi Arabia. Front Pediatr 2021; 13(9): 652857. https://doi.org/10.3389/fped.2021.652857 DOI: https://doi.org/10.3389/fped.2021.652857
DIG Gikar S, Nanjegowda R, Kumar A, Kumar V, Kulkarni S, Venkatagiri P. Neonatal Multi-system Inflammatory Syndrome secondary to SARS-CoV-2 infection. J Paediatr Child Health 2021; 13. https://doi.org/10.1111/jpc.15696 DOI: https://doi.org/10.1111/jpc.15696
Diwakar K, Gupta BK, Uddin MW, Sharma A, Jhajra S. Multi-system inflammatory syndrome with persistent neutropenia in neonate exposed to SARS-CoV-2 virus: A case report and review of literature. J Neonatal Perinatal Med 2021. https://doi.org/10.3233/NPM-210839 DOI: https://doi.org/10.3233/NPM-210839
More K, Chawla D, Murki S, Tandur B, Deorari AK, Kumar P. National Neonatology Forum (NNF) COVID-19 Registry Group. Outcomes of neonates born to mothers with coronavirus disease 2019(COVID-19)—National Neonatology Forum (NNF) India COVID-19 Registry. Indian Pediatr 2021; 58(6): 525-531. https://doi.org/10.1007/s13312-021-2234-2 DOI: https://doi.org/10.1007/s13312-021-2234-2
Chawla D, Chirla D, Dalwai S, Deorari AK, Ganatra A, Gandhi A, Kabra NS, Kumar P, Mittal P, Parekh BJ, Sankar MJ, Singhal T, Sivanandan S, Tank P. Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF) and Indian Academy of Pediatrics (IAP). Perinatal-Neonatal Management of COVID-19Infection-Guidelines of the Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP). Indian Pediatr 2020; 57(6): 536-548. https://doi.org/10.1007/s13312-020-1852-4 DOI: https://doi.org/10.1007/s13312-020-1852-4
MOHFW Clinical management protocol: COVID 19 Version 3: 13/06/2020. https://www.mohfw.gov.in/pdf/Clinical Management Protocol for COVID-19.pdf
Centers for Disease Control and Prevention (2020) Multi-system inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). CDC Health Alert Net- work. https://www.cdc.gov/mis/about.html
Raschetti R, Vivanti AJ, Vauloup-Fellous C, Loi B, Benachi A, De Luca D. Synthesis and systematic review of reported neonatal SARS-CoV-2 infections. Nat Commun 2020; 11(1): 5164. https://doi.org/10.1038/s41467-020-18982-9 DOI: https://doi.org/10.1038/s41467-020-18982-9
Kobayashi T, Fuse S, Sakamoto N, Mikami M, Ogawa S, Hamaoka K, Arakaki Y, Nakamura T, Nagasawa H, Kato T, et al. A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population. J Am Soc EchocaRDiogr Off Publ Am Soc EchocaRDiogr 2016; 29: 794-801.e29. https://doi.org/10.1016/j.echo.2016.03.017 DOI: https://doi.org/10.1016/j.echo.2016.03.017
Alsaleem M. Intravenous Immune Globulin Uses in the Fetus and Neonate: A Review. Antibodies (Basel) 2020; 9(4): 60. https://doi.org/10.3390/antib9040060 DOI: https://doi.org/10.3390/antib9040060
Navarro M, Negre S, Matoses ML, Golombek SG, Vento M. Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the neonate. Acta Paediatr 2009; 98: 1214-1217. https://doi.org/10.1111/j.1651-2227.2009.01279.x DOI: https://doi.org/10.1111/j.1651-2227.2009.01279.x
Whitworth HB, Sartain SE, Kumar R, Armstrong K, Ballester L, Betensky M, Cohen C, Diaz R, Diorio C, Goldenberg NA, et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood 2021. https://doi.org/10.1182/blood.2020010218 DOI: https://doi.org/10.1182/blood.2020010218
Lakshminrusimha S, Hudak M, Dimitriades V, HIG Gins RD. Multi-system Inflammatory Syndrome (MIS-C) in Neonates (MIS-N) Following Maternal SARS CoV-2 COVID-19 Infection. Am J Perinatol 2021. https://doi.org/10.1055/a-1682-3075 DOI: https://doi.org/10.1055/a-1682-3075
Gray KJ, BoRDt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, Medina Baez A, Shook LL, Cvrk D, James K, et al. COVID-19 vaccine response in pregnant and lactating women: A cohort study. Am J Obstet Gynecol 2021. https://doi.org/10.1101/2021.03.07.21253094 DOI: https://doi.org/10.1101/2021.03.07.21253094
KabeeRDoss J, Pilania RK, Karkhele R, Kumar TS, Danda D, Singh S. Severe COVID-19, multi-system inflammatory syndrome in children, and Kawasaki disease: Immunological mechanisms, clinical manifestations, and management. Rheumatol Int 2021; 41: 19-32. https://doi.org/10.1007/s00296-020-04749-4 DOI: https://doi.org/10.1007/s00296-020-04749-4
Anderson EM, Diorio C, Goodwin EC, McNerney KO, Weirick ME, Gouma S, Bolton MJ, Arevalo CP, Chase J, Hicks P, et al. SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19. J Pediatric Infect Dis Soc 2020. https://doi.org/10.1101/2020.08.17.20176552 DOI: https://doi.org/10.1101/2020.08.17.20176552
Vella LA, Giles JR, Baxter AE, Oldridge DA, Diorio C, Kuri-Cervantes L, Alanio C, Pampena MB, Wu JE, Chen Z, et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci Immunol 2021; 6. https://doi.org/10.1101/2020.09.25.20201863 DOI: https://doi.org/10.1101/2020.09.25.20201863
Gruber CN, Patel RS, Trachtman R, Lepow L, Amanat F, Krammer F, Wilson KM, Onel K, Geanon D, Tuballes K, et al. Mapping Systemic Inflammation and Antibody Responses in Multi-system Inflammatory Syndrome in Children (MIS-C). Cell 2020; 183: 982-995. https://doi.org/10.1016/j.cell.2020.09.034 DOI: https://doi.org/10.1016/j.cell.2020.09.034
Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W, Long X. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. JAMA J Am Med Assoc 2020. https://doi.org/10.1001/jama.2020.4861 DOI: https://doi.org/10.1001/jama.2020.4861
Atyeo C, Pullen KM, BoRDt EA, Fischinger S, Burke J, Michell A, Slein MD, Loos C, Shook LL, Boatin AA, et al. Compromised SARS-CoV-2-specific placental antibody transfer. Cell 2021; 184: 628-642.e10. https://doi.org/10.1016/j.cell.2020.12.027 DOI: https://doi.org/10.1016/j.cell.2020.12.027
Blumberg D, Sridhar A, Lakshminrusimha S, HIG Gins RD, Saade G. COVID-19 Vaccine Considerations during Pregnancy and Lactation. Am J Perinatol 2021; 38: 523-528. https://doi.org/10.1055/s-0041-1726390 DOI: https://doi.org/10.1055/s-0041-1726390
Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, Marquez PL, Olson CK, Liu R, Chang KT, et al. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med 2021. https://doi.org/10.1097/01.aoa.0000796052.11696.42 DOI: https://doi.org/10.1097/01.aoa.0000796052.11696.42
Metz TD, Clifton RG, Hughes BL, Sandoval G, Saade GR, Grobman WA, Manuck TA, Miodovnik M, Sowles A, Clark K, et al. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol 2021; 137: 571-580. https://doi.org/10.1097/AOG.0000000000004339 DOI: https://doi.org/10.1097/AOG.0000000000004339
Published
How to Cite
Issue
Section
License
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .
